nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

18.01.2024 | Image of the Month

[¹⁸F]F-AlF-NOTA-octreotide PET/CT detected the [¹⁸F]FDG negative ectopic ACTH tumor in mediastinum

verfasst von: Lin Chen, Ying Zhang, Chentao Jin, Rui Zhou, Hong Zhang

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Excerpt

A 28-year-old male presented with bilateral ankle edema, red cheeks, and moon face without obvious cause 2 months ago. The results of laboratory examinations pointed to the diagnosis of ectopic adrenocorticotropic hormone (ACTH) syndrome. However, regular imaging examinations did not find any lesions. The patient then underwent [¹⁸F]FDG and [¹⁸F]F-AlF-NOTA-octreotide PET/CT to screen the underlying source for ectopic ACTH syndrome. …

Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. The Lancet. 2015;386:913–27. https://doi.org/10.1016/s0140-6736(14)61375-1.CrossRef

Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, et al. Conventional and nuclear medicine imaging in ectopic Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab. 2015;100:3231–44. https://doi.org/10.1210/JC.2015-1589.CrossRefPubMedPubMedCentral

Elin P, Frederik C, Térence T, Michel K, Kim S, Lennert B, et al. ¹⁸F-AlF-NOTA-octreotide outperforms ⁶⁸Ga-DOTATATE/NOC PET in neuroendocrine tumor patients: results from a prospective, multicenter study. J Nucl Med. 2023;64:632. https://doi.org/10.2967/jnumed.122.264563.CrossRef

Boeckxstaens L, Pauwels E, Vandecaveye V, Deckers W, Cleeren F, Dekervel J, et al. Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients. EJNMMI Res. 2023;13:53. https://doi.org/10.1186/s13550-023-01003-3.CrossRefPubMedPubMedCentral

Long T, Yang N, Zhou M, Chen D, Li Y, Li J, et al. Clinical application of 18F-AlF-NOTA-octreotide PET/CT in combination with 18F-FDG PET/CT for imaging neuroendocrine neoplasms. Clin Nucl Med. 2019;44:452–8. https://doi.org/10.1097/RLU.0000000000002578.CrossRefPubMed

Roya M, Mostafapour S, Mohr P, Providencia L, Li Z, van Snick JH, et al. Current and future use of long axial field-of-view positron emission tomography/computed tomography scanners in clinical oncology. Cancers. 2023;15. https://doi.org/10.3390/cancers15215173.

Titel: [18F]F-AlF-NOTA-octreotide PET/CT detected the [18F]FDG negative ectopic ACTH tumor in mediastinum
verfasst von: Lin Chen
Ying Zhang
Chentao Jin
Rui Zhou
Hong Zhang
Publikationsdatum: 18.01.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2024
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-024-06613-0

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

[¹⁸F]F-AlF-NOTA-octreotide PET/CT detected the [¹⁸F]FDG negative ectopic ACTH tumor in mediastinum

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2024

Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [177Lu]Lu-DOTATATE radiopharmaceutical therapy

Surgical evidence-based comparison of [68Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients

Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin αvβ3

False-positive [18F]FAPI-74 uptake caused by blood retention due to external jugular vein thrombus: Pitfall in the early-phase scan

MIDOS: a novel stochastic model towards a treatment planning system for microsphere dosimetry in liver tumors

On the rational use of thyroid scintigraphy in thyrotoxic patients in the age of integrated diagnostics